Researchers from the University of Chicago (IL, USA) have published findings indicating that genetic variations appear to predispose children to developing certain severe forms of neuroblastoma. The report, published in the Journal of the National Cancer Institute, focused specifically on MYCN-amplified neuroblastoma and could aid the development of more targeted treatments for pediatric brain cancers.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.